Pharmaceuticals
Healthcare
Invictus Oncology raises $1.88M in Series A from Navam Capital, Aarin Capital & others
Delhi-based Invictus Oncology Pvt Ltd has raised Rs 10.50 crore (around $1.88 million) in Series A funding led by Navam Capital ......
Healthcare
US-based Gavis Pharma makes open offer to acquire 26% more in Bangalore's Wintac
US-based Gavis Pharma LLC has made an open offer to acquire an additional 26 per cent stake in Bangalore’s Wintac ......
Healthcare
Drugmaker Valeant to buy Bausch & Lomb for $8.7B from Warburg Pincus
Valeant Pharmaceuticals International said on Monday it agreed to buy Bausch & Lomb Holdings Inc from Warburg Pincus LLC for ......
Healthcare
Wockhardt says FDA alert affects potential sales of $100M
Drug maker Wockhardt Ltd said up to $100 million in annualised revenue could be lost as a result of a ......
Healthcare
Fresenius comes with delisting offer for Indian arm, may cost up to $72M
German healthcare firm Fresenius SE & Co. KGaA has made a delisting offer for its Gurgaon-based pharmaceutical arm Fresenius Kabi ......
Healthcare
SAI Life Sciences eyeing $10M in fresh funding in 2014
Hyderabad-based SAI Life Sciences Ltd, a drug discovery, development and manufacturing partner to pharmaceutical companies, is eyeing to raise around ......
Healthcare
How biotech firm Richcore is deploying the capital raised from Fidelity Growth Partners
Bangalore-based biotechnology firm Richcore Lifesciences Pvt Ltd, which raised $5.4 million (around Rs 30 crore) from Fidelity Growth Partners India ......
Healthcare
Fulcrum to invest $4M in pharma company Shield Healthcare, values it at $10-11M
Early-stage investor Fulcrum Venture India is investing around Rs 21.82 crore ($4 million) through multiple tranches in Chennai-based pharmaceutical company ......
Healthcare
Healthcare-focused investor OrbiMed buys stake in Claris Lifesciences
A fund managed by the private equity firm OrbiMed Advisors has picked up close to 3 per cent stake in ......
Healthcare
India reserves right to act on patents after Novartis case
Commerce and Industry Minister Anand Sharma said India would revoke drug patents if outbreaks of serious diseases or pandemics made ......
